FDA-Approved Stem Cells Treatments
According to the FDA, there are currently only a limited number of stem cell therapies approved by the agency—including ones involving bone marrow, for bone marrow transplants in cancer care, and cord blood for specific blood-related disorders.
FDA-Approved Treatments
LEUKEMIAS
MYELODYSPLASTIC SYNDROMES
LYMPHOMAS
OTHER DISORDERS OF BLOOD CELL PROLIFERATION
INHERITED RED CELL ABNORMALITIES
INHERITED PLATELET ABNORMALITIES
INHERITED IMMUNE SYSTEM DISORDERS
NEUTROPENIAS
OTHER
LYMPHOPROLIFERATIVE DISORDERS
MYELOPROLIFERATIVE DISORDERS
PHAGOCYTE DISORDERS
TRANSPLANTS FOR INHERITED METABOLIC DISORDERS
LEUKODYSTROPHY DISORDERS
LYSOSOMAL STORAGE DISEASES
INHERITED DISORDERS: OTHER
SOLID TUMORS NOT ORIGINATING IN THE BLOOD OR IMMUNE SYSTEM
Interested in learning whether current clinical programs, research developments, or emerging therapeutic approaches may be relevant to your situation?
Educational and research information only. Individual medical decisions should be made in consultation with qualified healthcare professionals.
